Pediatrix Medical Group, Inc. Operating Income Loss

• Pediatrix Medical Group, Inc. showed an increase of +403.9% in Operating Income Loss from 2024 to 2025.
• This data is from Pediatrix Medical Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2008 to 2025), Pediatrix Medical Group, Inc.'s Operating Income Loss has declined by 13.7%.
• Historical annual values: Fiscal year 2025: $208.81 million | Fiscal year 2024: -$68.71 million | Fiscal year 2023: $7.32 million | Fiscal year 2022: $172.69 million | Fiscal year 2021: $202.92 million | Fiscal year 2020: $98.13 million | Fiscal year 2019: $171.76 million | Fiscal year 2018: $248.39 million | Fiscal year 2017: $454.89 million | Fiscal year 2016: $571.69 million | Fiscal year 2015: $557.87 million | Fiscal year 2014: $513.00 million | Fiscal year 2013: $452.13 million | Fiscal year 2012: $389.52 million | Fiscal year 2011: $355.39 million | Fiscal year 2010: $312.91 million | Fiscal year 2009: $288.93 million | Fiscal year 2008: $242.03 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026